
Could at-home test strips prevent drug deaths? Experts say yes, but it's complicated
Dr. Nash Denic, Newfoundland and Labrador's chief medical examiner, says that though the strips aren't perfect, they can be useful in detecting if some toxins are present. He would like to see a government-led pilot project to distribute the strips along with naloxone kits, which reverse the effects of opioid overdoses.
'There is a possibility that harm can be reduced. Especially if you're a novice and you're trying a different type of drug, you want to test it first,' Denic said in an interview, adding that if used properly, test strips 'can save your life.'
Dr. Alexander Caudarella, chief executive officer of the Canadian Centre on Substance Abuse, also sees a benefit in making test strips more available to people in their homes.
'We know most of the people in this country are not dying on the streets — they're dying behind locked doors in their own apartments or houses,' Caudarella said in a recent interview.
The strips can be part of a larger strategy to stay safe, which includes not consuming drugs alone, he said.
But there are caveats. The tests need to be used properly and they won't say how much contaminant is present, only that it's there. The number of toxins they can detect is limited. Fentanyl test strips, for example, won't pick up newer opioids, Caudarella said.
'It's not going to tell people exactly what's in their drugs, but we find these tools can be really important to help people understand just how contaminated the drugs that they're buying are,' he said.
This is especially important for people who believe their drugs are safe because they purchased them from a website or a person they trust, he added.
BTNX Inc.'s Rapid Response tests are among the most widely used tests strips in Canada. The Ontario-based company has strips for contaminants including fentanyl, xylazine, benzodiazepine and nitazene. The company's website says clearly that the strips don't test for drug purity or safety — they can only say if the target contaminant is present.
The strips can be purchased in Canada online, or they can be found at safe consumption sites or through other harm reduction services. They are placed in a small amount of the drug, which has been dissolved in water. A line appears on the strip to indicate the presence of contaminants.
For those who need the strips immediately, and who may not use or have access to harm reduction services, options are limited. BTNX is still working to offer them for sale in large retail chains, spokesperson Molly McKay said.
The company is also aware the test strips can miss toxic contaminants. 'We're continuously working with our third-party researchers to determine what those blind spots are, and then we make corrections,' McKay said in an interview.
Two teenagers died this year in Newfoundland and Labrador after taking pills contaminated with nitazene, a potent synthetic opioid, and bromazolam, a benzodiazepine which can be lethal when taken with opioids, said Denic, the chief medical examiner. Xylazine, a veterinary sedative, is a common contaminant in cocaine. And fentanyl deaths in the province show no signs of abating, though they've recently been overtaken by cocaine.
Test strips could help people stay safer from some of these toxins, Denic said. A positive test result may convince someone not to use the drug or to use much less of it.
Ian Culbert, executive director of the Canadian Public Health Association, said ideally, it would be easier for people to have their drugs checked by more advanced equipment, like the tests available at some safe consumption sites in the country. Their results are more accurate, and they can be used to track contaminants in the local drug supply.
During Elections
Get campaign news, insight, analysis and commentary delivered to your inbox during Canada's 2025 election.
'In most parts of the country, you can walk into any community pharmacy and request a take-home naloxone kit. That is how accessible well-developed drug-checking tests should be,' Culbert said in a recent interview.
But still, take-home test strips are 'better than nothing,' he said.
Some have misguided beliefs that expanding drug-checking services will ultimately encourage more drug use, Culbert said. He worries those ideas turn decision-makers away from making it easier to check and test drugs.
'There is a continuum of public health interventions that all can help reduce the number of deaths associated with the toxic drug crisis. Drug checking is one of them,' Culbert said. 'We need to be investing across the spectrum, not just ideologically picking the ones that suit the agenda of the government of the day.'
This report by The Canadian Press was first published April 24, 2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Vancouver Sun
an hour ago
- Vancouver Sun
Opinion: The monumental challenge of expensive drugs for rare diseases
The Vancouver Sun recently published an article on the resignation of Dr. Sandra Sirrs from the province's Expensive Drugs for Rare Diseases Advisory Committee over a decision by the minster of health to continue funding Brineura to treat a rare condition suffered by 10-year-old Charleigh Pollock, after Dr. Sirrs's committee recommended discontinuation. As was mentioned in the article, the Ministry of Health has requested the UBC Therapeutics Initiative to review the effectiveness of Brineura for the rare condition known as neuronal ceroid lipofuscinosis type 2 (CLN2) disease. The Therapeutics Initiative will not be reviewing or commenting on Pollock's case, but we feel it is important to highlight a few challenges posed by rare disease drugs that might provide some insights into why people of goodwill might disagree over government funding decisions. A daily roundup of Opinion pieces from the Sun and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Informed Opinion will soon be in your inbox. Please try again Interested in more newsletters? Browse here. While CLN2 disease is extremely rare, there are thousands of rare diseases, with estimates for the number of Canadians who have one between one million and three million. Advances in artificial intelligence, genetic and pharmacological research are accelerating the rate of discovery of new drugs to treat these conditions. Unfortunately, there are mounting problems coming with this good news. The problem that occupies much of the Therapeutics Initiative's time is how to evaluate the scientific evidence of drugs used by so few people. If you take a drug to lower cholesterol or blood pressure, your medication has been tested in thousands of people in high-quality randomized clinical trials, the gold standard for drug evaluation. A drug to treat a rare disease might only be studied in fewer than a hundred people worldwide, and it was almost certainly not studied using rigorous randomized clinical trials. Instead, almost all the rare disease studies involve detailed case studies or case series where the drug benefit is estimated compared to what is currently known about other children with the condition. The other challenge we face in evaluating drugs treating neurodegenerative conditions such as CLN2 is assessing the validity of effectiveness measurements. For example, effectiveness might be assessed in terms of slowing disease progression measured in terms of a cognitive or physical function scale. Although often in common use by clinicians, the actual predictive value of the scale has seldom been studied. The other problem in dealing with these drugs for rare diseases is their price. Drugs coming to market have been priced between $100,000 and $2 million per year for each patient. The vast majority are over $200,000 per year, with newer ones even more expensive. British Columbia spent $153 million dollars on rare disease drugs in the fiscal year ending in March 2024, and $101 million in 2023. The annual growth rate in the most recent five-year period averaged 48 per cent. At this growth rate, B.C. will pass $1.6 billion per year in five years. It will pass $11.3 billion annually in 10 years, solely devoted to drugs for less than one per cent of the population, equivalent to almost a third of today's total health-care budget. We therefore strongly empathize with experts like Dr. Sirrs who have the challenging task of making recommendations for very complex conditions, requiring intense clinical evaluations with relatively weak scientific evidence. We also strongly empathize with government decision makers forced to make these extremely difficult decisions. Colin Dormuth and Ken Bassett are co-directors of the Therapeutics Initiative, and members of the UBC Faculty of Medicine.


CTV News
2 hours ago
- CTV News
Londoners urged to check on vulnerable as temperatures soar under the sizzling sun
Local Ark Aid Mission sets up system to help provide critical relief from the heat. CTV London's Reta Ismail has the story. With a heat warning in effect and temperatures soaring, local health officials and outreach organizations are urging Londoners to take precautions and help protect the most vulnerable members of the community. Environment Canada issued a heat warning for the region, forecasting daytime highs between 30 and 33 degrees with humidex values reaching as high as 42. Overnight lows are expected to stay above 19, offering little relief. The heat wave is expected to persist through Tuesday night. In downtown London, the Ark Aid Mission has added a shaded patio and makeshift misting station to help people experiencing homelessness cool off. Steven, who is currently unhoused, says it makes a big difference. 'It keeps you cool, and they give shade,' he said. 'There's no other shade in the city except for trees. And, without it, I don't think a lot of people would survive, to tell you the truth.' Sarah Campbell, executive director of Ark Aid Mission says they are doing what they can to help during the heat warning. She added that the Ark Aid is funded for just four hours of daily service but is operating 8 hours Monday through Friday, and 12 hours on Saturday and Sunday. 'Much like our winter planning, we look to find ways to get people indoors, give them an opportunity to rest, make sure that they have proper nourishment,' she said. 'We are working with our partners to make sure there's an everyday location for lunch and dinner and breakfast. We really try to just take those basic needs one by one, having a shower, access to running water, a bathroom.' The Middlesex-London Health Unit is reminding residents that extreme heat can be dangerous and even deadly especially for the elderly, infants and people without adequate housing. 'It can start with symptoms such as sweating, just some general fatigue and cramps and stuff like that,' said Dave Pavletic, manager of environmental health at the health unit. 'And then it could lead to some more significant symptoms, which can be heatstroke which is a medical emergency.' Pavletic encourages residents to take it easy, avoid strenuous outdoor activity and check in on others who may be at risk. 'You want to make sure that you check on family and friends, particularly folks that are elderly and may not have air conditioning, because the indoor heat can be a significant concern too,' he said. Environment Canada says relief is on the way, with slightly lower temperatures expected by Wednesday.


Global News
4 hours ago
- Global News
Use of IUDs up after B.C. made birth control free
A new study shows more women opted for long-acting birth control methods after British Columbia began covering the cost, which researchers say is a strong reason for Ottawa's pharmacare plan to do the same. The study found prescriptions for all types of birth control jumped significantly after the province began covering contraceptives in April 2023, with a 49 per cent jump in prescriptions for intrauterine devices (IUDs) driving the increase. The paper published Monday in the BMJ examined the prescriptions of nearly 860,000 women in the 15 months after contraception coverage began and compared them to what would have been expected without coverage. Among prescriptions for women aged 15 to 49 between April 2023 and June 2024, 11,000 more women were prescribed IUDs, which are inserted into the uterus to prevent fertilization and considered 10 times more effective than pills or condoms. Story continues below advertisement 5:57 What Pharmacare expansion means for Canadians Reached in Vancouver, lead author Laura Schummers said IUDs can cost up to $450 out-of-pocket compared to approximately $25 for a month of pills, according to a government estimate. Though IUDs last at least three years, they cost more upfront. 'This tells us that costs alone are a huge barrier to the most effective methods of contraception across Canada,' said Schummers, an assistant professor of pharmaceutical sciences at the University of British Columbia. Schummers says these results clearly demonstrate the need for national pharmacare coverage, as affordable access is unequal across the country. Many other provinces will only cover contraception for those who are below a certain age or income. The federal government said just a fraction of Canadians are eligible for that low- or no-cost option. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy The British Columbia government started covering 100 per cent of the cost of all IUDs, such as copper and hormonal, contraceptive implants and injections, vaginal rings, most birth control pills and emergency oral contraceptives on April 1, 2023. Story continues below advertisement The federal government announced in October 2024 that it intended to cover the cost of contraception and diabetes medications. That required the government to negotiate and sign deals with each province and territory. The federal government announced in October 2024 that it intended to cover the cost of contraception and diabetes medications. That required the government to negotiate and sign deals with each province and territory. But the Liberal leadership changed ahead of the spring election. Last week, federal Health Minister Marjorie Michel said the Mark Carney government would not commit to signing pharmacare funding deals beyond the three provinces and one territory that did so under Justin Trudeau. Those include P.E.I., B.C., Manitoba and Yukon. A spokesperson for the minister says the government will protect the four deals that have been signed. Schummers says those who cannot afford IUDs may either choose cheaper but less effective methods, or forgo contraceptives altogether. 0:32 Pharmacare bill covering diabetes, birth control medications passes Senate 'This is not a small fraction of people who are falling through the cracks,' she says. Story continues below advertisement The study says that 15 months after the policy was implemented, there were 1,981 more monthly prescriptions filled when compared to what they were expecting based on pre-policy trends. Schummers says the increase in IUD use was seen across all age groups, but most pronounced for people aged 20 to 29, many who had previously not been using any prescription contraception. Halifax pharmacist Kari Ellen Graham says she's seen customers prescribed birth control leave empty-handed because of the cost. She said one woman was in an abusive relationship but could not afford to pay out-of-pocket for birth control. The next summer, she saw the woman with a newborn in tow. 'We see this all the time in gender-based violence and it's a really sad thing when people don't have reproductive autonomy,' Graham said. There are deductibles and copayment options for contraception in Nova Scotia, but both require the patient to pay at the counter. 'It's been decades that we've been having these conversations around birth control here in Nova Scotia and we are exactly where we were decades ago,' she said. Dr. Amanda Black, past president of the Society of Obstetricians and Gynecologists of Canada, said there's a financial incentive for the federal government to cover the cost of contraception. Story continues below advertisement A paper she authored in 2015 estimated the direct health-care cost of unintended pregnancies in Canada was at least $320 million per year, which she said is very likely higher in 2025. That figure accounted for the cost of abortions, ectopic pregnancies and births. She said UBC researchers in 2018 estimated that the provincial government breaks even within two years of funding birth control. 'After that the government is actually saving money,' said Black, a professor of obstetrics and gynecology at the University of Ottawa. Black said it would be a step backwards for women's health in Canada if the federal government stops signing pharmacare agreements with the provinces, particularly as reproductive rights are being rolled back in other parts of the world. 'We want to be moving forward and continue to move forward and this is one of the biggest things that has happened for women's gender equity in decades.' – with file from Sarah Ritchie This report by The Canadian Press was first published July 28, 2025. Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.